Skip to main content
Premium Trial:

Request an Annual Quote

More Kids

Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and it plans to include even younger children, the Associated Press reports.

Currently, the Moderna SARS-CoV-2 vaccine is authorized for use in individuals over the age of 18, though CNBC notes authorization for its use among children and teens aged 12 and over is expected soon. Pfizer's SARS-CoV-2 vaccine is currently authorized for adolescents between the ages of 12 and 15 as well as for people 16 and older.

The New York Times reports that the US Food and Drug Administration has asked both Moderna and Pfizer were asked to expand the sizes of their vaccine studies among 5 to 11-year-olds, in part to better detect rare side effects like heart inflammation. The FDA last month added a warning label to the Moderna and Pfizer SARS-CoV-2 vaccines to note that they were associated with risk of a rare inflammatory condition among teens and young adults.

The AP adds that Moderna also plans to expand its trial to include children as young as six months. Pfizer, the Times notes, expects to have results from its study of 5-year-olds to 11-year-olds in September, followed shortly by results from study of 2-year-olds to 5-year-olds, and it expects results from its study of 6-month-olds to 2-year-olds in October or November.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.